KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $55.6 million.

  • Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) rose 6.48% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 6.48%. This contributed to the annual value of $51.9 million for FY2024, which is 6.76% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Shares Outstanding (Diluted Average) stood at $55.6 million for Q3 2025, which was up 1.41% from $54.9 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) peaked at $1.9 billion during Q2 2023, and registered a low of $1.6 million during Q1 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $52.2 million (2024), whereas its average is $392.5 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) spiked by 119,130.92% in 2023 and then plummeted by 97.38% in 2024.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $1.4 billion in 2021, then plummeted by 96.91% to $42.0 million in 2022, then rose by 15.75% to $48.6 million in 2023, then rose by 6.76% to $51.9 million in 2024, then climbed by 6.48% to $55.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $55.6 million for Q3 2025, versus $54.9 million for Q2 2025 and $54.2 million for Q1 2025.